Scilex Holding Company Operating Lease Cost
Scilex Holding Company (SCLX) reported Operating Lease Cost of $469.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2023-03-07
- Scilex Holding Company operating lease, cost for fiscal 2022 was $469.00K, a 24.72% decline from fiscal 2021.
- Scilex Holding Company operating lease, cost for fiscal 2021 was $623.00K, a 31.08% decline from fiscal 2020.
- Scilex Holding Company operating lease, cost for fiscal 2020 was $904.00K.
| Period end | Operating Lease, Cost 12 month |
|---|---|
| 2022-12-31 | $469.00K 10-K · filed 2023-03-07 |
| 2021-12-31 | $623.00K 10-K · filed 2023-03-07 |
| 2020-12-31 | $904.00K 10-K · filed 2023-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |